Literature DB >> 27431268

Menaquinone as a potential target of antibacterial agents.

Atmika Paudel1, Hiroshi Hamamoto, Suresh Panthee, Kazuhisa Sekimizu.   

Abstract

The current trend of increasing infections by multidrug-resistant pathogens requires the discovery of novel antimicrobial agents with new target and selective toxicity towards pathogens. Menaquinone is a component of electron transport chains in a majority of anaerobic bacteria and Gram-positive bacteria. Due to its exclusivity in bacteria, menaquinone is thought to be a potential target for development of therapeutically effective antibacterial agents without side effects. In this review, we summarize inhibitors of menaquinone biosynthesis and antibiotics directly targeting menaquinone in bacteria.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27431268     DOI: 10.5582/ddt.2016.01041

Source DB:  PubMed          Journal:  Drug Discov Ther        ISSN: 1881-7831


  13 in total

1.  Lysocin E Targeting Menaquinone in the Membrane of Mycobacterium tuberculosis Is a Promising Lead Compound for Antituberculosis Drugs.

Authors:  Geberemichal Geberetsadik; Akane Inaizumi; Akihito Nishiyama; Takehiro Yamaguchi; Hiroshi Hamamoto; Suresh Panthee; Aki Tamaru; Manabu Hayatsu; Yusuke Mizutani; Shaban Amina Kaboso; Mariko Hakamata; Aleksandr Ilinov; Yuriko Ozeki; Yoshitaka Tateishi; Kazuhisa Sekimizu; Sohkichi Matsumoto
Journal:  Antimicrob Agents Chemother       Date:  2022-08-15       Impact factor: 5.938

2.  The Role of Amino Acid Substitution in HepT Toward Menaquinone Isoprenoid Chain Length Definition and Lysocin E Sensitivity in Staphylococcus aureus.

Authors:  Suresh Panthee; Atmika Paudel; Hiroshi Hamamoto; Anne-Catrin Uhlemann; Kazuhisa Sekimizu
Journal:  Front Microbiol       Date:  2020-08-26       Impact factor: 5.640

Review 3.  Enzymatic Transition States and Drug Design.

Authors:  Vern L Schramm
Journal:  Chem Rev       Date:  2018-10-18       Impact factor: 60.622

Review 4.  Advantages of the Silkworm As an Animal Model for Developing Novel Antimicrobial Agents.

Authors:  Suresh Panthee; Atmika Paudel; Hiroshi Hamamoto; Kazuhisa Sekimizu
Journal:  Front Microbiol       Date:  2017-03-07       Impact factor: 5.640

5.  Characterization of MenA (isoprenyl diphosphate:1,4-dihydroxy-2-naphthoate isoprenyltransferase) from Mycobacterium tuberculosis.

Authors:  Rakesh K Dhiman; Venugopal Pujari; James M Kincaid; Melanie A Ikeh; Tanya Parish; Dean C Crick
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240

Review 6.  Targeting adenylate-forming enzymes with designed sulfonyladenosine inhibitors.

Authors:  Michaelyn C Lux; Lisa C Standke; Derek S Tan
Journal:  J Antibiot (Tokyo)       Date:  2019-04-15       Impact factor: 2.649

7.  Structure-Based Design, Synthesis, and Biological Evaluation of Non-Acyl Sulfamate Inhibitors of the Adenylate-Forming Enzyme MenE.

Authors:  Christopher E Evans; Yuanyuan Si; Joe S Matarlo; Yue Yin; Jarrod B French; Peter J Tonge; Derek S Tan
Journal:  Biochemistry       Date:  2019-03-26       Impact factor: 3.162

8.  New Insights Into the Antibacterial Mechanism of Cryptotanshinone, a Representative Diterpenoid Quinone From Salvia miltiorrhiza Bunge.

Authors:  Bo-Chen Chen; Zhi-Shan Ding; Jian-Sheng Dai; Ni-Pi Chen; Xing-Wen Gong; Lie-Feng Ma; Chao-Dong Qian
Journal:  Front Microbiol       Date:  2021-02-25       Impact factor: 5.640

9.  Aminofutalosine Deaminase in the Menaquinone Pathway of Helicobacter pylori.

Authors:  Mu Feng; Rajesh K Harijan; Lawrence D Harris; Peter C Tyler; Richard F G Fröhlich; Morais Brown; Vern L Schramm
Journal:  Biochemistry       Date:  2021-06-02       Impact factor: 3.321

10.  A Challenging View: Antibiotics Play a Role in the Regulation of the Energetic Metabolism of the Producing Bacteria.

Authors:  Marie-Joelle Virolle
Journal:  Antibiotics (Basel)       Date:  2020-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.